483
Fresenius Kabi USA, LLCFDA 483 - Fresenius Kabi USA, LLC - August 30, 2023
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
An FDA inspection of Fresenius Kabi USA, LLC, a medical device manufacturer in Grand Island, NY, revealed deficiencies in their corrective and preventive action (CAPA) procedures. The firm's CAPA process allows for actions to not include verification or validation of effectiveness under certain conditions, and two out of five reviewed CAPAs lacked this crucial step.
- Office
- New York District Office
- Person
Open in Dashboard
ID · 91efc984-74c0-4435-9a5c-15f4efbc26a7